$OPK
OPKO HEALTH, INC. Stock $opk

$opk Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000094480919000034 Filed on May 08, 2019

Income Statement

Concept	2019 Q2	2019 Q1	2018 Q1
Revenue	$226.4M	$222.5M	$254.9M
YoY Change	-14.15%	-12.73%	-4.31%
Cost Of Revenue	$144.2M	$144.1M	$139.4M
YoY Change	-3.93%	3.34%	-0.38%
Gross Profit	$82.10M	$78.40M	$115.5M
YoY Change	-27.73%	-32.11%	-8.66%
Gross Profit Margin	36.27%	35.24%	45.3%
Selling, General & Admin	$88.48M	$95.16M	$91.52M
YoY Change	0.94%	3.98%	-16.76%
% of Gross Profit	107.76%	121.38%	79.26%
Research & Development	$28.29M	$36.53M	$32.89M
YoY Change	-3.17%	11.07%	23.84%
% of Gross Profit	34.45%	46.59%	28.48%
Depreciation & Amortization	$23.66M	$23.82M	$24.76M
YoY Change	-4.45%	-3.8%	-3.78%
% of Gross Profit	28.82%	30.38%	21.44%
Operating Expenses	$273.6M	$297.8M	$297.5M
YoY Change	1.8%	0.08%	-4.52%
Operating Profit	-$47.26M	-$75.32M	-$42.61M
YoY Change	825.22%	76.76%	-5.76%
Interest Expense	-$5.300M	-$3.800M	-$800.0K
YoY Change	1225.0%	375.0%	-127.59%
% of Operating Profit
Other Income/Expense, Net	-$11.19M	-$2.807M	$1.061M
YoY Change	-237.53%	-364.56%	-82.01%
Pretax Income	-$58.45M	-$78.13M	-$41.55M
YoY Change	-2029.71%	88.03%	5.68%
Income Tax	$1.084M	$783.0K	-$892.0K
% Of Pretax Income
Net Earnings	-$59.81M	-$80.76M	-$43.11M
YoY Change	864.46%	87.32%	24.96%
Net Earnings / Revenue	-26.42%	-36.31%	-16.91%
Basic Earnings Per Share
Diluted Earnings Per Share	-$102.0K	-$137.8K	-$77.03K
COMMON SHARES
Basic Shares Outstanding	615.6M shares	615.6M shares	559.5M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q2	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$111.1M	$207.3M	$99.90M
YoY Change	38.18%	107.51%	-23.8%
Cash & Equivalents	$111.1M	$207.3M	$99.94M
Short-Term Investments
Other Short-Term Assets	$3.234M	$4.511M	$4.370M
YoY Change	-32.12%	3.23%	13.57%
Inventory	$48.29M	$44.61M	$49.82M
Prepaid Expenses
Receivables	$148.3M	$144.4M	$158.6M
Other Receivables	$18.80M	$19.40M	$25.40M
Total Short-Term Assets	$344.2M	$435.2M	$349.3M
YoY Change	7.05%	24.59%	-24.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$137.1M	$140.0M	$148.7M
YoY Change	-8.69%	-5.89%	17.79%
Goodwill	$699.8M	$712.0M	$719.9M
YoY Change	-2.02%	-1.1%	1.97%
Intangibles
YoY Change
Long-Term Investments	$24.30M	$31.40M	$36.30M
YoY Change	-44.39%	-13.5%	6.14%
Other Assets	$3.770M	$3.126M	$5.627M
YoY Change	-28.14%	-44.45%	-85.53%
Total Long-Term Assets	$2.112B	$2.140B	$2.230B
YoY Change	-4.41%	-4.01%	-3.07%
TOTAL ASSETS
Total Short-Term Assets	$344.2M	$435.2M	$349.3M
Total Long-Term Assets	$2.112B	$2.140B	$2.230B
Total Assets	$2.456B	$2.575B	$2.579B
YoY Change	-2.95%	-0.14%	-6.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$60.38M	$51.09M	$64.23M
YoY Change	-12.58%	-20.46%	-13.85%
Accrued Expenses	$198.4M	$217.5M	$217.1M
YoY Change	-1.3%	0.18%	21.39%
Deferred Revenue	$50.39M	$65.29M	$61.38M
YoY Change	-18.53%	6.37%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$14.30M	$115.4M	$40.10M
YoY Change	-64.25%	187.78%	247.88%
Total Short-Term Liabilities	$283.4M	$396.1M	$318.1M
YoY Change	-7.65%	24.52%	20.05%
LONG-TERM LIABILITIES
Long-Term Debt	$4.500M	$4.322M	$1.432M
YoY Change	164.08%	201.82%	-2.05%
Other Long-Term Liabilities	$127.8M	$78.17M	$233.6M
YoY Change	-39.0%	-66.54%	23.23%
Total Long-Term Liabilities	$463.9M	$416.5M	$437.6M
YoY Change	12.17%	-4.81%	12.73%
TOTAL LIABILITIES
Total Short-Term Liabilities	$283.4M	$396.1M	$318.1M
Total Long-Term Liabilities	$463.9M	$416.5M	$437.6M
Total Liabilities	$747.3M	$812.6M	$755.6M
YoY Change	3.73%	7.53%	15.7%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.337B	-$1.277B	-$1.075B
YoY Change	23.61%	18.76%	47.61%
Common Stock	$6.162M	$6.162M	$5.600M
YoY Change	10.0%	10.04%	0.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.791M	$1.791M	$1.791M
YoY Change	0.0%	0.0%	-6.28%
Treasury Stock Shares	549.9K shares	549.9K shares	549.9K shares
Shareholders Equity	$1.709B	$1.763B	$1.823B
YoY Change
Total Liabilities & Shareholders Equity	$2.456B	$2.575B	$2.579B
YoY Change	-2.95%	-0.14%	-6.56%

Cashflow Statement

Concept	2019 Q2	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	-$59.81M	-$80.76M	-$43.11M
YoY Change	864.46%	87.32%	24.96%
Depreciation, Depletion And Amortization	$23.66M	$23.82M	$24.76M
YoY Change	-4.45%	-3.8%	-3.78%
Cash From Operating Activities	-$53.60M	-$48.99M	-$35.52M
YoY Change	213.45%	37.92%	4.72%
INVESTING ACTIVITIES
Capital Expenditures	-$3.500M	-$2.900M	-$6.000M
YoY Change	-48.53%	-51.67%	-36.84%
Acquisitions
YoY Change
Other Investing Activities	$300.0K	-$1.200M	$800.0K
YoY Change	0.0%	-250.0%	-74.19%
Cash From Investing Activities	-$3.200M	-$4.132M	-$5.146M
YoY Change	-51.52%	-19.7%	-20.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-39.30M	$163.9M	$49.19M
YoY Change	-1082.5%	233.14%	2162.7%
NET CHANGE
Cash From Operating Activities	-53.60M	-$48.99M	-$35.52M
Cash From Investing Activities	-3.200M	-$4.132M	-$5.146M
Cash From Financing Activities	-39.30M	$163.9M	$49.19M
Net Change In Cash	-96.10M	$110.8M	$8.444M
YoY Change	387.82%	1211.9%	-122.11%
FREE CASH FLOW
Cash From Operating Activities	-$53.60M	-$48.99M	-$35.52M
Capital Expenditures	-$3.500M	-$2.900M	-$6.000M
Free Cash Flow	-$50.10M	-$46.09M	-$29.52M
YoY Change	386.41%	56.12%	20.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	597316000	USD
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000944809
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	615601045	shares
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	Opko Health, Inc.
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2018Q4	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	11	institution
CY2018Q3	opk	Number Of Derivative Lawsuits NumberOfDerivativeLawsuits	12	lawsuit
CY2017	opk	Overpayments Received Duration OverpaymentsReceivedDuration	P10Y
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	586881720	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	616150952	shares
CY2018	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.01
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	549907	shares
CY2019Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	549907	shares
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	207250000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	96473000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	144383000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	143907000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	44610000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	42299000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	38994000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35052000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	614452000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	144674000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	435237000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	317731000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	139965000	USD
CY2019Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	635561000	USD
CY2018Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	635572000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	698522000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	700193000	USD
CY2019Q1	us-gaap	Long Term Investments LongTermInvestments	32297000	USD
CY2018Q4	us-gaap	Long Term Investments LongTermInvestments	31228000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33277000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3126000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7222000	USD
CY2019Q1	us-gaap	Assets Assets	2575301000	USD
CY2018Q4	us-gaap	Assets Assets	2451072000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	51085000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	47395000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	217534000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	203513000	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15123000	USD
CY2019Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2018Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	31562000	USD
CY2019Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	112316000	USD
CY2018Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	5851000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	396058000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	288321000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	18621000	USD
CY2019Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	203711000	USD
CY2018Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	57299000	USD
CY2019Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	116009000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	115193000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	78165000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	198968000	USD
CY2019Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	416506000	USD
CY2018Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	371460000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	812564000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	659781000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	6162000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	5869000	USD
CY2019Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1791000	USD
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1791000	USD
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3058509000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3004422000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-23229000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20131000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1276914000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1197078000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1762737000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1791291000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2575301000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2451072000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	222451000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	254914000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	95158000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	91519000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36529000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32887000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	4806000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1759000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16562000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17271000	USD
CY2019Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	655000	USD
CY2018Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	297769000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	297525000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-75318000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-42611000	USD
CY2019Q1	opk	Interest Income Nonoperating InterestIncomeNonoperating	556000	USD
CY2018Q1	opk	Interest Income Nonoperating InterestIncomeNonoperating	39000	USD
CY2019Q1	opk	Interest Expense Nonoperating InterestExpenseNonoperating	4755000	USD
CY2018Q1	opk	Interest Expense Nonoperating InterestExpenseNonoperating	2267000	USD
CY2019Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	415000	USD
CY2018Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1396000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	977000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1893000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2807000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1061000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-78125000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-41550000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	783000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-892000	USD
CY2019Q1	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-78908000	USD
CY2018Q1	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-40658000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1854000	USD
CY2018Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2456000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-80762000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-43114000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	586344207	shares
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	559473838	shares
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-80762000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-43114000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3098000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4865000	USD
CY2019Q1	opk	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax	0	USD
CY2018Q1	opk	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax	4876000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-83860000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-43125000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1791291000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4457000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-3000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	50852000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-80762000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3098000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1762737000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1843623000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5936000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-43114000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4865000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1811310000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-80762000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-43114000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23816000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24757000	USD
CY2019Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	3010000	USD
CY2018Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	843000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	405000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	43000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1854000	USD
CY2018Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2456000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4457000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5936000	USD
CY2019Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-284000	USD
CY2018Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	261000	USD
CY2019Q1	opk	Increase Decrease In Equity Securities Fvni And Derivative Instruments IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments	1825000	USD
CY2018Q1	opk	Increase Decrease In Equity Securities Fvni And Derivative Instruments IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments	3101000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	4806000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1759000	USD
CY2019Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	655000	USD
CY2018Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-352000	USD
CY2018Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2709000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	439000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6757000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2475000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-204000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	46000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5445000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	243000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	131000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3713000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-10206000	USD
CY2019Q1	opk	Increase Decreasein Foreign Currency Measurement IncreaseDecreaseinForeignCurrencyMeasurement	-23000	USD
CY2018Q1	opk	Increase Decreasein Foreign Currency Measurement IncreaseDecreaseinForeignCurrencyMeasurement	-11000	USD
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-18073000	USD
CY2018Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-15358000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	12250000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-8829000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-48988000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35520000	USD
CY2019Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1200000	USD
CY2018Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1000000	USD
CY2019Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	USD
CY2018Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	1286000	USD
CY2019Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
CY2018Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	541000	USD
CY2019Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2932000	USD
CY2018Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	5973000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4132000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5146000	USD
CY2019Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	200293000	USD
CY2018Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	55000000	USD
CY2019Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7762000	USD
CY2018Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2019Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	-3000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
CY2019Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	35460000	USD
CY2018Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	6611000	USD
CY2019Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	35313000	USD
CY2018Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	12420000	USD
CY2019Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	28800000	USD
CY2018Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	163875000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	49191000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	22000	USD
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-81000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	110777000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8444000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	96473000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	91499000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	207250000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99943000	USD
CY2019Q1	us-gaap	Interest Paid InterestPaid	511000	USD
CY2018Q1	us-gaap	Interest Paid InterestPaid	641000	USD
CY2019Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1022000	USD
CY2018Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2292000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	33277000	USD
CY2019Q1	opk	Operating Lease Liability Initial Recognition Upon Adoption OperatingLeaseLiabilityInitialRecognitionUponAdoption	33744000	USD
CY2019Q1	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	20000	USD
CY2018Q1	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	0	USD
CY2019Q1	opk	Numberof Sales Employees NumberofSalesEmployees	300	employee
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	Use of estimates. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.
CY2019Q1	us-gaap	Inventory Write Down InventoryWriteDown	500000	USD
CY2018Q1	us-gaap	Inventory Write Down InventoryWriteDown	0.0	USD
CY2019Q1	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	1900000000	USD
CY2018Q4	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	2000000000.0	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16600000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17300000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	7300000	USD
CY2018Q1	us-gaap	Depreciation Depreciation	7500000	USD
CY2019Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of credit risk and allowance for doubtful accounts<span style="font-family:inherit;font-size:10pt;">. Financial instruments that potentially subject us to concentrations of credit risk consist primarily of accounts receivable. Substantially all of our accounts receivable are with either companies in the healthcare industry or patients. However, credit risk is limited due to the number of our clients as well as their dispersion across many different geographic regions.</span>While we have receivables due from federal and state governmental agencies, we do not believe that such receivables represent a credit risk since the related healthcare programs are funded by federal and state governments, and payment is primarily dependent upon submitting appropriate documentation.
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2000000.0	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1800000	USD
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	USD
CY2018Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	100000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4500000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5900000	USD
CY2019Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2019Q1	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	24877	shares
CY2019Q1	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	19232	shares
CY2019Q1	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	24877	shares
CY2019Q1	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	5645	shares
CY2018Q1	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	0	shares
CY2019Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	146333000	USD
CY2018Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	145665000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1950000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1758000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	144383000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	143907000	USD
CY2019Q1	us-gaap	Other Inventory Supplies OtherInventorySupplies	21599000	USD
CY2018Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	23264000	USD
CY2019Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18891000	USD
CY2018Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	15259000	USD
CY2019Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	2851000	USD
CY2018Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2473000	USD
CY2019Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	4729000	USD
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4259000	USD
CY2019Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3460000	USD
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2956000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	44610000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	42299000	USD
CY2019Q1	opk	Taxes Recoverable Current TaxesRecoverableCurrent	19893000	USD
CY2018Q4	opk	Taxes Recoverable Current TaxesRecoverableCurrent	15708000	USD
CY2019Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	-457000	USD
CY2018Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	2368000	USD
CY2019Q1	us-gaap	Supplies Supplies	12200000	USD
CY2018Q4	us-gaap	Supplies Supplies	9693000	USD
CY2019Q1	us-gaap	Prepaid Insurance PrepaidInsurance	2847000	USD
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	3436000	USD
CY2019Q1	us-gaap	Other Assets Current OtherAssetsCurrent	4511000	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3847000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	38994000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35052000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	274977000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	258539000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	597316000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	614452000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	65288000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	63503000	USD
CY2019Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	42354000	USD
CY2018Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	45621000	USD
CY2019Q1	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	11996000	USD
CY2018Q4	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	10401000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2375000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2375000	USD
CY2019Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3077000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3280000	USD
CY2019Q1	opk	Business Combination Deferred Acquisition Payments Netof Discount Current BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent	4919000	USD
CY2018Q4	opk	Business Combination Deferred Acquisition Payments Netof Discount Current BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent	4871000	USD
CY2019Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	6689000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7935000	USD
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	80836000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	65527000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	217534000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	203513000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7708000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	27566000	USD
CY2019Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
CY2018Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	105198000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	26968000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	22162000	USD
CY2019Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4322000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4654000	USD
CY2019Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4981000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	5620000	USD
CY2019Q1	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	34186000	USD
CY2018Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	33768000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	78165000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	198968000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	700193000	USD
CY2019Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-1671000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	698522000	USD
CY2019Q1	opk	Equity Method Investment Excluding Variable Interest Entity EquityMethodInvestmentExcludingVariableInterestEntity	2197000	USD
CY2019Q1	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	9760000	USD
CY2019Q1	opk	Equity Method Investment Variable Interest Entity EquityMethodInvestmentVariableInterestEntity	1059000	USD
CY2019Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	27723000	USD
CY2019Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	438000	USD
CY2019Q1	opk	Stock Optionand Warrant Investments StockOptionandWarrantInvestments	880000	USD
CY2019Q1	us-gaap	Long Term Investments LongTermInvestments	32297000	USD
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	171300000	USD
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	51500000	USD
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-35300000	USD
CY2019Q1	us-gaap	Equity Method Investment Quoted Market Value EquityMethodInvestmentQuotedMarketValue	14500000	USD
CY2019Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	1410000	USD
CY2019Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2019Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	1410000	USD
CY2019Q1	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	11	institution
CY2019Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	197171000	USD
CY2019Q1	us-gaap	Line Of Credit LineOfCredit	110031000	USD
CY2018Q4	us-gaap	Line Of Credit LineOfCredit	108710000	USD
CY2019Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	27723000	USD
CY2019Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	880000	USD
CY2019Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	28734000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	29343000	USD
CY2019Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	29343000	USD
CY2018Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	26313000	USD
CY2018Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	855000	USD
CY2018Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	27189000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	24537000	USD
CY2018Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	24537000	USD
CY2019Q1	opk	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease Ten Percent BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecreaseTenPercent	1800000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	29300000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	24500000	USD
CY2018Q4	opk	Private Placement Agreement Sale Of Shares Shares PrivatePlacementAgreementSaleOfSharesShares	26500000	shares
CY2018Q4	opk	Private Placement Agreement Sale Of Shares Price Per Share PrivatePlacementAgreementSaleOfSharesPricePerShare	3.49
CY2018Q4	opk	Private Placement Agreement Sale Of Shares Amount PrivatePlacementAgreementSaleOfSharesAmount	92500000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	29300000	USD
CY2018Q4	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	100000	USD
CY2018Q3	opk	Number Of Class Action Lawsuits NumberOfClassActionLawsuits	7	lawsuit
CY2019Q1	us-gaap	Purchase Obligation PurchaseObligation	93500000	USD
CY2019Q1	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	8400000	USD
CY2018Q1	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	15700000	USD
CY2019Q1	opk	Accrued Expense Payor Overpayment Reimbursement Liability AccruedExpensePayorOverpaymentReimbursementLiability	35600000	USD
CY2018Q4	opk	Accrued Expense Payor Overpayment Reimbursement Liability AccruedExpensePayorOverpaymentReimbursementLiability	35900000	USD
CY2019Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	73000000.0	USD
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	91100000	USD
CY2017Q4	opk	Proceeds From Development And License Agreement Upfront Payment ProceedsFromDevelopmentAndLicenseAgreementUpfrontPayment	6000000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	USD
CY2019Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-75318000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-42611000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23816000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24757000	USD
CY2019Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1854000	USD
CY2018Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2456000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	222451000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	254914000	USD
CY2019Q1	us-gaap	Assets Assets	2575301000	USD
CY2018Q4	us-gaap	Assets Assets	2451072000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	698522000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	700193000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33277000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	8058000	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15123000	USD
CY2019Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3077000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	18621000	USD
CY2019Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4981000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2019Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.052
CY2019Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.037
CY2019Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	2418000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	12348000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10065000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2698000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6613000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1937000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3734000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	827000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2318000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	273000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2087000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	201000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	37165000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	8354000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3421000	USD
CY2019Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	296000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	33744000	USD
CY2019Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	8058000	USD
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	5700000	USD
CY2019Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1700000	USD
CY2019Q1	us-gaap	Variable Lease Cost VariableLeaseCost	1700000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	5742000	USD
CY2019Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	191000	USD
CY2019Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	660000	USD
CY2019Q1	opk	Payments For Leases PaymentsForLeases	6593000	USD

Files In Submission

Name	View Source	Status
0000944809-19-000034-index-headers.html	Edgar Link	pending
0000944809-19-000034-index.html	Edgar Link	pending
0000944809-19-000034.txt	Edgar Link	pending
0000944809-19-000034-xbrl.zip	Edgar Link	pending
ex101brli-xamendmentno.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opk-20190331.xsd	Edgar Link	pending
opk-20190331_cal.xml	Edgar Link	unprocessable
opk-20190331_def.xml	Edgar Link	unprocessable
opk-20190331_lab.xml	Edgar Link	unprocessable
opk-20190331_pre.xml	Edgar Link	unprocessable
opk-3312019x10q.htm	Edgar Link	pending
opk-3312019x10q_htm.xml	Edgar Link	completed
opk-3312019xex311.htm	Edgar Link	pending
opk-3312019xex312.htm	Edgar Link	pending
opk-3312019xex321.htm	Edgar Link	pending
opk-3312019xex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPK
OPKO HEALTH, INC. Stock $opk

2019 Q2 Form 10-Q Financial Statement

#000094480919000034 Filed on May 08, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK OPKO HEALTH, INC. Stock $opk

2019 Q2 Form 10-Q Financial Statement

#000094480919000034 Filed on May 08, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK
OPKO HEALTH, INC. Stock $opk